Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,195 | 8,791 | 12,972 | 17,303 | 1,117 |
| TOTAL | $115,630 | $9,971 | $14,276 | $19,000 | $1,150 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5 | 14 | 25 | 31 |
| Intangibles | 48,648 | 0 | 1,867 | 1,867 | 0 |
| Other Non-Current Assets | 32,907 | 955 | 869 | 0 | 15 |
| TOTAL | $81,555 | $960 | $2,750 | $1,892 | $46 |
| Total Assets | $197,185 | $10,931 | $17,026 | $20,892 | $1,196 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,447 |
| Accounts payable and accrued liabilities | 1,366 | 329 | 689 | 418 | 338 |
| Accrued Expenses | 973 | 813 | 1,845 | 1,022 | 113 |
| TOTAL | $2,483 | $1,322 | $2,534 | $1,440 | $3,898 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 144 | 0 | 0 | 0 |
| TOTAL | $4,106 | $144 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,589 | $1,466 | $2,534 | $1,440 | $3,898 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,307 | 893 | 525 | 523 | 140 |
| Common Shares | 15 | 1 | 9 | 7 | N/A |
| Retained earnings | -80,393 | -57,582 | -41,571 | -27,506 | -14,390 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 291 |
| TOTAL | $190,596 | $9,465 | $14,492 | $19,452 | $-2,702 |
| Total Liabilities And Equity | $197,185 | $10,931 | $17,026 | $20,892 | $1,196 |